<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Harada N</submitter><funding>Takeda Science Foundation</funding><funding>Japan Agency for Medical Research and Development</funding><funding>Hoansha Foundation</funding><funding>Japan Science and Technology Agency</funding><funding>Japan Society for the Promotion of Science</funding><pagination>e71286</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12486328</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>14(19)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>We have previously developed a gold nanoparticle (GNP)-based anti-cancer immunotherapy, termed integrated glyco-nanovaccine (iGN). The iGN is composed of GNPs conjugated to a synthetic toll-like receptor (TLR) 7 ligand, an antigen peptide, and a mannose sugar chain. However, the effect of the combination of different sugar chains and antigen peptides on iGN-mediated anticancer immunotherapy remains to be elucidated.&lt;h4>Objective&lt;/h4>We compared the anti-tumor effects of two different sugar chains: α-mannose and sialic acid.&lt;h4>Results&lt;/h4>We showed that not only the sugar chain but also the antigen peptide plays a pivotal role in iGN uptake by immune cells. In contrast to α-mannose, which promoted GNP internalization by bone marrow-derived dendritic cells (BMDC), sialic </pubmed_abstract><journal>Cancer medicine</journal><pubmed_title>Peptide Modulation Overrides Glycan Synergy in Gold Nanoparticle-Based Vaccines for Cancer Immunotherapy.</pubmed_title><pmcid>PMC12486328</pmcid><funding_grant_id>JPMJFR226J</funding_grant_id><funding_grant_id>JP22cm0106382</funding_grant_id><funding_grant_id>24H00864</funding_grant_id><funding_grant_id>24H00865</funding_grant_id><funding_grant_id>JPMJPR17HA</funding_grant_id><funding_grant_id>JP22gm6210030</funding_grant_id><pubmed_authors>Sakamoto Y</pubmed_authors><pubmed_authors>Wada S</pubmed_authors><pubmed_authors>Moroishi T</pubmed_authors><pubmed_authors>Shimoda M</pubmed_authors><pubmed_authors>Shinchi H</pubmed_authors><pubmed_authors>Murata K</pubmed_authors><pubmed_authors>Wakao M</pubmed_authors><pubmed_authors>Niimura M</pubmed_authors><pubmed_authors>Harada N</pubmed_authors><pubmed_authors>Kamba T</pubmed_authors><pubmed_authors>Nita A</pubmed_authors></additional><is_claimable>false</is_claimable><name>Peptide Modulation Overrides Glycan Synergy in Gold Nanoparticle-Based Vaccines for Cancer Immunotherapy.</name><description>&lt;h4>Background&lt;/h4>We have previously developed a gold nanoparticle (GNP)-based anti-cancer immunotherapy, termed integrated glyco-nanovaccine (iGN). The iGN is composed of GNPs conjugated to a synthetic toll-like receptor (TLR) 7 ligand, an antigen peptide, and a mannose sugar chain. However, the effect of the combination of different sugar chains and antigen peptides on iGN-mediated anticancer immunotherapy remains to be elucidated.&lt;h4>Objective&lt;/h4>We compared the anti-tumor effects of two different sugar chains: α-mannose and sialic acid.&lt;h4>Results&lt;/h4>We showed that not only the sugar chain but also the antigen peptide plays a pivotal role in iGN uptake by immune cells. In contrast to α-mannose, which promoted GNP internalization by bone marrow-derived dendritic cells (BMDC), sialic </description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Oct</publication><modification>2026-06-04T01:26:51.527Z</modification><creation>2026-05-03T03:14:11.285Z</creation></dates><accession>S-EPMC12486328</accession><cross_references><pubmed>41031725</pubmed><doi>10.1002/cam4.71286</doi></cross_references></HashMap>